Regen Med Investor Day Webcast

7:30am         Breakfast & Networking

8:00am         Welcome Remarks

Geoff MacKay, Chair, ARM; President & CEO, Organogenesis

8:10am         Featured Speaker

Kieran Murphy, VP, President & CEO, GE Healthcare Life Sciences

8:30am         Featured Speaker

Jeff Jonas, M.D., President, Shire Regenerative Medicine

8:50am         Program Introduction

Jason Kolbert, Managing Director, Biotechnology Research, Maxim Group

9:00am         Clinical Outlooks in Cardiovascular Disease

Jason Kolbert, Managing Director, Biotechnology Research, Maxim Group (moderator)

Ronnda Bartel, Ph.D., CSO, Aastrom Biosciences

Marc Hedrick, M.D., President, Cytori Therapeutics, Inc.

Silviu Itescu, M.B.B.S., CEO & President, Mesoblast Ltd.

Linda Marban, Ph.D., Founder & CEO, Capricor

Leslie Miller, M.D., Director, USF Heart Institute; Director, Cardiovascular Regenerative Medicine Program, University of South Florida

9:55am         Break

10:10am       Regenerative Medicine in Wound Healing & Tissue Engineering

Ted Tenthoff, Managing Director & Senior Biotechnology Analyst, Piper Jaffray (moderator)

Milka Bedikian, Vice President, Global Marketing, Bioactive Wound Healing, Organogenesis Inc.

Pierre Gosselin, Ph.D., Senior Director, Business Development, Shire Regenerative Medicine

Will Li, M.D., President & Medical Director, The Angiogenesis Foundation

Martin Rosendale, CEO, Cytomedix, Inc.

Thomas Serena, M.D., F.A.C.S., CEO & Medical Director, SerenaGroup

11:05am       Therapeutics for a Broad Range of CNS Diseases

Reni Benjamin, Ph.D., Managing Director & Senior Biotechnology Analyst, Burrill Securities (moderator)

Aileen Anderson, Ph.D., Associate Professor, Department of Anatomy & Neurobiology, University of California, Irvine

Lucian Del Priore, M.D., Ph.D., Pierre G. Jenkins Professor, Chairman, Department of Ophthalmology & Director, Storm Eye Institute

Stephen Huhn, M.D., F.A.C.S., Vice President, Head of the CNS Program, StemCells, Inc. Gary Rabin, Chairman & CEO, Advanced Cell Technology

Sean Savitz, M.D., Professor of Neurology, University of Texas Medical School, UTHealth

Gil Van Bokkelen, Ph.D., Chairman & CEO, Athersys, Inc.

Lawrence Wechsler, M.D., Professor & Chair, Department of Neurology, University of Pittsburgh

12:00pm       Plated Lunch & Networking

12:30pm       Lunchtime Presentation

Introduction: Susan Solomon, CEO & Co-Founder, New York Stem Cell Foundation

Speaker: G. Steven Burrill, CEO, Burrill & Company

1:00pm         Cytori Therapeutics, Inc. – Marc Hedrick, M.D., President

1:15pm         Athersys, Inc. - Gil Van Bokkelen, Ph.D., Chairman & CEO

1:30pm         Juventas Therapeutics - Rahul Aras, Ph.D., President & CEO

1:45pm         Aastrom Biosciences – Nick Colangelo, President & CEO

2:00pm         NeoStem – Jonathan Sackner-Bernstein, M.D., VP, Clinical Development & Regulatory Affairs

2:15pm         Pluristem Therapeutics - Zami Aberman, Chairman & CEO

2:30pm         Cytomedix, Inc. - Martin Rosendale, CEO

2:45pm         Sangamo BioSciences - Edward Lanphier, President & CEO

3:00pm         Afternoon Break

3:15pm         Tigenix - Eduardo Bravo, Managing Director & CEO 

3:30pm         StemCells, Inc. - Martin McGlynn, President & CEO 

3:45pm         Mesoblast Limited - Silviu Itescu, M.B.B.S., CEO & President 

4:00pm         Advanced Cell Technology (ACT) - Gary Rabin, Chairman & CEO

4:15pm         Organogenesis - Geoff MacKay, President & CEO

4:30pm         Organovo - Keith Murphy, Chairman & CEO

4:45pm         Asterias Biotherapeutics - Thomas Okarma, M.D., Ph.D., President & CEO

5:00pm         MiMedx Group – Michael Senken, Chief Financial Officer

5:15pm         Program Wrap-up